| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02728323 Details | 2020-08-12 Interventional | 3 | 96 | Levobupivacaine Pain, Postopera… Pain | Terminated - | |||
| NCT02728310 Details | 2020-08-12 Interventional | 3 | [1 Refs] | 96 | Levobupivacaine Pain, Postopera… Pain | Terminated - | ||
| NCT01868984 Details | 2020-08-12 Interventional | 2 | 10 | Heparin Paclitaxel Constriction, P… Fistula Fistula Stenosi… | catheters no longer available - difficult to recruit subjects - | |||
| NCT01685658 2015-002381-23 Details | 2020-08-12 Interventional | 4 | 0 | Acetaminophen Ketoprofen Colic Emergencies Renal Colic Acute Renal Col… | same study already published - | |||
| NCT03035253 Details | 2020-08-11 Interventional | 1 | 16 | Antibodies, Bis… Colorectal Neop… Metastatic Colo… | - - | |||
| NCT01225172 Details | 2020-08-11 Interventional | 2 | 77 | Letrozole Breast Neoplasm… Breast Cancer | Business objectives have changed. - | |||
| NCT03449524 Details | 2020-08-10 Interventional | 2 | 69 | CXA-10 Hypertension Pulmonary Arter… PAH | LOE - | |||
| NCT04327401 Details | 2020-08-07 Interventional | 3 | 299 | Dexamethasone Acute Lung Inju… Coronavirus Inf… Pneumonia, Vira… Respiratory Dis… Respiratory Dis… Acute Respirato… Coronavirus Inf… | The Data Monitoring Committee recommended to stop the trial based on the Recovery Trial
results, which was accepted by the CoDEX Steering Committee. - | |||
| NCT02566889 2015-001653-32 Details | 2020-08-06 Interventional | 4 | 53 | Infliximab Inflammatory Bo… Intestinal Dise… | Study was terminated due to the inability to enroll a sufficient number of the required subject
population Study was terminated due to the inability to enroll a sufficient number of the required participants. | |||
| NCT01341730 Details | 2020-08-06 Interventional | 4 | 41 | Atorvastatin Pioglitazone Atherosclerosis Carotid Artery … Coronary Artery… | - - | |||
| NCT03587129 Details | 2020-08-05 Interventional | 2 | [15 Refs] | 1 | Apatinib Carcinoma, Ovar… Ovarian Neoplas… Ovarian Cancer | No patient enter this study. - | ||
| NCT03006562 Details | 2020-08-05 Interventional | 4 | [1 Refs] | 501 | Heparin Embolism Lymphocele Pulmonary Embol… Thromboembolism Thrombosis Venous Thromboe… Venous Thrombos… Deep Venous Thr… Lymphocele Afte… Prostate Cancer | Early stopping point based on 2nd interim analysis (planned per protocol) The study met a futility end point at the 2nd interim analysis (pre-planned in the study protocol) leading to an appropriate decision for early closure and termination rather than continuing to planned enrollment of N=666. | ||
| NCT03469258 Details | 2020-08-03 Interventional | 2 | 4 | Pancreatin Pancrelipase Adenocarcinoma Pancreatic Neop… Pancreatic Canc… | Sponsorship for trial was halted after company acquisition Early termination per sponsor leading to small numbers of subjects enrolled. Those subjects who were enrolled did not meet pathologic criteria to remain on study and would have been replaced had the study continued. | |||
| NCT01677572 2012-000349-10 Details | 2020-08-03 Interventional | 1 | 197 | Immunoglobulin … Alzheimer Disea… Alzheimer's Dis… | Study was discontinued based on futility analysis conducted on Phase 3 trials (NCT02477800 and
NCT02484547) and not based on safety concerns. - | |||
| NCT04412252 Details | 2020-07-31 Interventional | 2 | 0 | Tofacitinib COVID-19 Pneumonia | Due to the pursuit of other SARS-CoV-2-related research including alternative trials with
tofacitinib, this trial was canceled prior to subject enrollment. - | |||
| NCT04329611 Details | 2020-07-31 Interventional | 3 | 148 | Hydroxychloroqu… COVID-19 | Enrolment was suspended on 22may2020, after Mehra et al (Lancet 2020) then stopped due to lack
of Covid19 cases. - | |||
| NCT03907813 Details | 2020-07-31 Interventional | 4 | 0 | Bupivacaine Pain, Postopera… Opioid Use | change in design - | |||
| NCT03740945 Details | 2020-07-31 Interventional | 3 | [8 Refs] | 0 | Dehydroepiandro… Atrophy Breast Neoplasm… Vaginal Atrophy… | Business decision to not perform this study. - | ||
| NCT03681951 Details | 2020-07-31 Interventional | 2 | 8 | Pembrolizumab Pancreatic Neop… Neoplasms, Panc… | The study was terminated following an internal review of the company's current research and
development portfolio. - | |||
| NCT03619005 Details | 2020-07-31 Interventional | 3 | 0 | Dehydroepiandro… Hypokinesia Sexual Dysfunct… Hypoactive Sexu… | Business decision to not continue this study (only few subjects were screened). - |